Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study by Elena Barbuti, Alessia Castiello, Valeria Pozzilli, Antonio Carotenuto, Ilaria Tomasso, Marcello Moccia, Serena Ruggieri, Giovanna Borriello, Roberta Lanzillo, Vincenzo Brescia Morra, Carlo Pozzilli, Maria Petracca

Get full text